Clinical Trial Update: A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer [Phase 3]

View source ↗

Summary

A pivotal Phase 3 trial is examining the safety and effectiveness of NanoKnife Irreversible Electroporation for Stage III pancreatic cancer. The study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• NanoKnife IRE (Irreversible electroporation)

Snippet

Sponsor: Angiodynamics, Inc. | Conditions: Stage III Pancreatic Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING